If those pages do not work and you believe you are receiving this message in error, please reach out to [email protected].
Branded GLP-1 Rx Support: Insurance coverage assistance starting at $69/mo membership
A detailed monograph with references is in the Featured section of my profile
Semaglutide once-weekly: improved observed endpoints with a new laboratory profile warning [PMID: 30296182] Laboratory literature summary: Semaglutide once-weekly: improved observed endpoints with a new laboratory profile warning
Many patients find that after losing 1520% of body weight, their baseline GERD improves significantly sometimes enough to stop reflux medication entirely
N Engl J Med 384(11):9891002 Wilding JPHBR, Calanna S, Van Gaal LF, McGowan BM, Rosenstock J, Tran MTD, Wharton S, Yokote K, Zeuthen N, Kushner RF (2021) Impact of semaglutide on body composition in adults with overweight or obesity: exploratory analysis of the STEP 1 study